Cover Image
Market Research Report
Product code 
787277

Global Allergy Diagnostics Market, Size, Share, Opportunities and Forecast, 2020-2027

Published: | DataM Intelligence | 180 Pages | Delivery time: 2 business days

Price

Back to Top
Global Allergy Diagnostics Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021
DataM Intelligence
Content info: 180 Pages
Delivery time: 2 business days
  • ALL
  • Description
  • Table of Contents
Description

Global Allergy Diagnostics Market is segmented By Product Type(Assay Kits, Consumables), By Allergen Type(Inhaled Allergens, Food Allergens, Drug Allergens), By End-User(Hospital-based laboratories, Diagnostic Laboratories, Academic Research Laboratories), By Test Type(In vivo test), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis,2020-2027

Market Overview

The Global Allergy Diagnostics Market is expected to grow at a CAGR of 10.3% during the forecasting period (2020-2027).

Allergic diseases include allergic rhinitis (hay fever), food allergies, forms of asthma, conjunctivitis, eczema, eosinophilic disorders, drug and insect allergies.

Diagnostic allergy testing in such scenarios is an essential tool for the evaluation of the patient.

Global Allergy Diagnostics market is anticipated to reach USD 4 billion by 2026.

Industry Analysis

Primary market drivers include rising allergic diseases with severe environmental pollution.

On the other hand, the growth of this market is hindered due to limited awareness about allergy diagnosis, food allergy, food intolerance and low affordability in developing countries.

Hence, allergic diseases like a food allergy and food intolerance are underestimated and underdiagnosed, particularly in low and middle-income countries.

Asia-Pacific is expected to show fast growth over the forecast period owing to an increase in pollution in developing countries like India and China.

Market Segmentation

Global Allergy Diagnostics market report segments the market by products, allergen type, test type, end-user and by region.

Based on product type, the market is classified into assay kits and consumables.

Based on the type of allergen responsible for causing allergy, the market is segmented into a drug, food, and inhaled allergens.

Inhaled allergens segment accounts for the largest share of Allergy Diagnostics market. Increasing environmental pollution is one of the major factors driving the growth of this segment.

Based on end-user, the market is segmented into diagnostic laboratories, hospital-based laboratories, academic & research institutes, diagnostics kits, and other end users.

In 2017, diagnostic laboratories segment accounted for the largest share.

Based on the type of test used for allergy testing, the market is segmented into two categories, namely In vivo test and In-vitro test.

In vivo test includes skin testing while in vitro test comprises serological tests.

Geographical Analysis

The market is segmented into five major regions: North America, South America, Europe, Asia Pacific, and RoW.

North America holds the highest market share of around 40%.

This is fueled by the high incidence of allergies, the presence of advanced allergy diagnostic technologies, as well as the strong presence of players in the region.

Market Segmentation

By Product Type

Assay Kits

Consumables

By Allergen Type

Inhaled Allergens

Food Allergens

Drug Allergens

By End-User

Hospital-based laboratories

Diagnostic Laboratories

Academic Research Laboratories

By Region

Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

North America (The USA, Canada, Mexico)

South America (Brazil, Argentina, Rest of South America)

Rest of the World

Allergy Diagnostics Industry Competition Size

The report also profiles the following companies in Allergy Diagnostics Treatment market - BioMerieux, Danaher Corporation, GlaxoSmithKline plc, Hitachi Chemical Diagnostics, Inc., Merck & Co, Inc, Omega Diagnostics Group PLC, Siemens Healthcare, and Thermo Fisher Scientific, Inc

Reasons for purchasing this report

Visualize the composition of Allergy Diagnostics market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.

Identify commercial opportunities by analyzing trends.

Excel data sheet with thousands of data points of the market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for crucial Allergy Diagnostics products of all major market players

Who are the key vendors in the allergy diagnostics market space?

Equipment Suppliers/ Buyers

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Related Reports

Influenza Diagnostics Market

Table of Contents

Table of Contents

Table of Content

1. Allergy Diagnostics Market - Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Scope of the Report

2. Allergy Diagnostics Market - Industry Trends

  • 2.1 Key Trends & Developments

3. Allergy Diagnostics Market - Opportunities

  • 3.1 Market Drivers

Environmental pollution contributing to the increasing incidence of allergic conditions

  • 3.2 Market Restraints

Lack of awareness about allergic diseases

Low affordability of allergy diagnostics

  • 3.3 Threats and Opportunities
  • 3.4 Porter's 5 Forces

4. Product-based Analysis

  • 4.1 By Product Type

Assay Kits

Consumables

  • 4.2 By Allergen Type

Inhaled Allergens

Food Allergens

Drug Allergens

  • 4.3 By End-User

Hospital-based laboratories

Diagnostic Laboratories

Academic Research Laboratories

  • 4.4 By Test Type

In vivo test

5. Regional, Country-level Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5 Rest of the World

6. Industry Competitiveness

  • 6.1. Market Share Analysis
  • 6.2. Mergers and Acquisitions Analysis
  • 6.3. New Product Launches

7. Company Profiles

  • 7.1 bioMerieux
  • 7.2 Danaher Corporation
  • 7.3 GlaxoSmithKline Plc
  • 7.4 Hitachi Chemical Diagnostics, Inc.
  • 7.5 Merck & Co., Inc.
  • 7.6 Omega Diagnostics Group PLC
  • 7.7 Siemens Healthcare
  • 7.8 Thermo Fisher Scientific, Inc.
  • 7.9 Stallergenes

8. Appendix

  • 8.1 Sources
  • 8.2 List of Tables
  • 8.3 Expert Panel Validation
  • 8.4 Disclaimer
  • 8.5 Contact Us